glp-1 drugs cancer Receptor Agonists Show a Striking Signal in Breast Outcomes, but Big Questions Remain New study examines GLP-1 drugs
Description
Week 4-6 : GI symptoms usually show noticeable improvement for many continuing users
Bottom line: The absolute best thing is to use reliable birth control while on GLP-1s so this doesnt happen
However, the added agonism of GIPR seems to have a more positive impact on weight loss
The researchers admit that the follow-up period was relatively short between 1.8 to three years
:max_bytes(150000):strip_icc()/VWHealth-Could-GLP-1Drugs-Reduce-Obesity-Related-Cancers-in-the-Future-3-7d602ab39c0448ddb00cd91b06be2a84.jpg)
Many patients maintain weight loss a year after stopping semaglutide and liraglutide
Frontiers in Clinical Diabetes and Healthcare
